Literature DB >> 17600937

Distribution of human papillomavirus types in different histological subtypes of cervical adenocarcinoma.

Ita Hadzisejdć1, Maja Krasević, Herman Haller, Blazenka Grahovac.   

Abstract

Little information is available regarding distribution of HPV types in different histological subtypes of adenocarcinoma (AC). Thus, in this study we examined the frequency of high-risk (hr) HPV types in AC, adenocarcinoma in situ (AIS) and adenosquamous carcinoma (ADSQ). A total of 102 cases of primary cervical adenocarcinoma (26 AIS and 76 invasive AC) obtained from pathology files from 1995-2006 were histologically subtyped. Our results demonstrated that endocervical type occupied the major subtype of AC (22/66) followed by ADSQ (17/66) where as in the group of AIS endocervical type (12/23) was followed by intestinal type of AIS (7/23). Successful DNA extraction was obtained in 89 samples; 81 out of 89 (91.0%) tested positive for HPV DNA. The prevalence of HPV DNA in AIS, AC and ADSQ was 91.3% (21/23), 90.9% (60/66) and 94.1% (16/17), respectively. We found HPV 18 type to be the most predominant type in AIS (11/21) and AC (17/60) followed by HPVof undeternmined type in AIS (3/21) and HPV 16 in AC (9/60) as the sole viral type. HPV 18 was most frequently detected type in all histological subtypes of AIS and AC. We have detected HPV DNA in all 5 samples of clear cell carcinoma (CCC), although other studies have reported a highly variable prevalence of HPVDNA in CCC. The most prevalent HPV type in ADSQ was HPV-16 followed by HPV 33 as single type. The observed overall predominance of HPV 18 in AIS (chi(2) = 6.109, p< or = 0.025) and AC (chi(2) = 8.927, p< or =0.01) as well as of HPV 16 in ADSQ (chi(2) = 10.164, p < or = 0.01) was statistically significant. Our data revealed statistically significant predominance of single hrHPV infections in AIS (16/21; chi(2) = 11.523, p < 0.001) and AC (37/60; X2 = 6.533, p < 0.025) whereas multiple hrHPV infections were more abundant in AC comparing to AIS (23/81and 5/81, respectively; chi(2) = 13.989, p< or =0.001).

Entities:  

Mesh:

Year:  2007        PMID: 17600937

Source DB:  PubMed          Journal:  Coll Antropol        ISSN: 0350-6134


  5 in total

1.  Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.

Authors:  Shinichi Togami; Yuko Sasajima; Takahiro Kasamatsu; Rie Oda-Otomo; Satoshi Okada; Mitsuya Ishikawa; Shun-ichi Ikeda; Tomoyasu Kato; Hitoshi Tsuda
Journal:  Pathol Oncol Res       Date:  2014-11-05       Impact factor: 3.201

2.  The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix.

Authors:  Sul Lee; Hyun Joo Lee; Kyung Un Choi; Byung Su Kwon; Dong Soo Suh; Dae Hoon Jeong; Geun Joo Kim; Tae Hwa Lee; Hyun-Jin Roh; Ki Hyung Kim
Journal:  J Res Med Sci       Date:  2020-05-22       Impact factor: 1.852

3.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

4.  Polymerase chain reaction and deoxyribonucleic acid-sequencing based study on distribution of human papillomavirus 16/18 among histopathological types of cervical intra-epithelial neoplasia and primary invasive cervical carcinoma: A scenario in North Bengal, India.

Authors:  Prithwijit Ghosh; Damayanti Das Ghosh; Amita Majumdar Giri; Sharmila Sengupta; Chandana Das; Indranil Mukhopadhyay
Journal:  J Midlife Health       Date:  2014-01

5.  Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study.

Authors:  Binhua Dong; Pengming Sun; Guanyu Ruan; Weiyi Huang; Xiaodan Mao; Yafang Kang; Diling Pan; Fen Lin
Journal:  Cancer Manag Res       Date:  2018-10-23       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.